Avoro Capital Advisors LLC

CIK 0001633313 · NEW YORK, NY · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Avoro Capital Advisors LLC reported 26 positions worth $11.14B as of June 30, 2026 (13F filed August 14, 2026). Largest holding: UTHR (13.5%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$11.14B
2026 Q2
Positions
26
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
79.5%
Est. Net Flow (Q)
2026 Q2
10 / 26 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1UTHRUNITED THERAPEUTICS CORPSH$1.51B13.52%2,777,777
2ASNDASCENDIS PHARMASH$1.36B12.24%5,111,111
3KRYSKRYSTAL BIOTECH INCSH$1.07B9.64%2,888,888
4MDGLMADRIGAL PHARMACEUTICALS INCSH$984.4M8.84%1,833,333
5ARGXARGENX SESH$927.8M8.33%1,000,000
6ARWRARROWHEAD PHARMACEUTICALS INCSH$925.6M8.31%11,355,555
7KYMRKYMERA THERAPEUTICS INCSH$857.1M7.70%7,474,747
8RVMDREVOLUTION MEDICINES INCSH$430.2M3.86%2,297,000
9CYTKCYTOKINETICS INCSH$425.9M3.82%4,999,999
10CELCCELCUITY INCSH$355.7M3.19%3,400,000

The free plan shows the top 10 positions. The remaining 16 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Avoro Capital Advisors LLC hold as of Q2 2026?

Avoro Capital Advisors LLC reported 26 positions worth $11.14B in its Q2 2026 13F filing. Largest positions: UTHR (13.5%), ASND (12.2%), KRYS (9.6%), MDGL (8.8%) and ARGX (8.3%).

What did Avoro Capital Advisors LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Avoro Capital Advisors LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.